With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1608-26-0,N,N,N’,N’,N”,N”-Hexamethylphosphinetriamine,as a common compound, the synthetic route is as follows.
General procedure: A solution of methyl iodide (1.14 g, 8 mmol) was added dropwise for 1 min to the stirringmixture of tertiary phosphine (4 mmol) in anhydrous tetrahydrofuran (16 mL) at roomtemperature. After the mixture was stirred at room temperature for 12 h, the mixture wasevaporated in vacuo. The residue was washed with ether, and the precipitate was dried invacuo for 12 h at 40 C to give corresponding quaternary phosphonium iodide as a whitepowder.
1608-26-0, As the paragraph descriping shows that 1608-26-0 is playing an increasingly important role.
Reference£º
Article; Aoyagi, Naoto; Furusho, Yoshio; Endo, Takeshi; Tetrahedron Letters; vol. 54; 51; (2013); p. 7031 – 7034;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate